cancer Archives
Ukrainian oncologists visit Vanderbilt-Ingram Cancer Center
Nov. 30, 2023—A group of Ukrainian oncologists recently visited Vanderbilt-Ingram Cancer Center where they toured research labs, observed tumor board meetings, met with several Vanderbilt oncologists, and attended the 23rd Annual Retreat for Cancer Biology.
Vanderbilt-led team receives 2023 Endeavor Award from The Mark Foundation for Cancer Research
Oct. 24, 2023—A multidisciplinary team of investigators has received a 2023 Endeavor Award from The Mark Foundation for Cancer Research to support four closely linked projects exploring the fundamental mechanisms that drive the obesity-cancer connection,
Discovery lecture features computational cancer biologist Pe’er
Sep. 12, 2023—Dana Pe’er, PhD, a pioneer in using machine learning approaches to explore cell identities and interactions, will deliver the next Discovery Lecture on Thursday, Sept. 21.
VUMC named a Comprehensive Radiopharmaceutical Therapy Center of Excellence
Aug. 23, 2023—Vanderbilt University Medical Center has been designated a Comprehensive Radiopharmaceutical Therapy Center of Excellence by the Society of Nuclear Medicine and Molecular Imaging. It is the only such center in Tennessee.
Chronic complications from immunotherapies more prevalent and persistent than previously shown among melanoma survivors
Aug. 8, 2023—A Vanderbilt study has found that chronic immunotherapy-related complications are more prevalent and persistent than previously shown among melanoma survivors.
Study finds hallmarks of T cell exhaustion within hours of tumor exposure
Aug. 3, 2023—Vanderbilt researchers found that T cells become “exhausted” within hours of encountering a tumor, challenging existing ideas about how T cells become dysfunctional.
Signaling pathways in liposarcomas
Jul. 25, 2023—A broad bioinformatics approach revealed that Hedgehog signaling is upregulated in dedifferentiated liposarcoma, suggesting this pathway may be an early indicator of poor prognosis and a potential therapeutic target.
Symposium offers new ways to overcome health disparities
Jun. 14, 2023—Ideas for addressing the disproportionate impact of cancer, diabetes, and gastrointestinal diseases on disadvantaged populations were shared recently during a diversity symposium at Vanderbilt University Medical Center.
Study discovers that tumor mutation burden predicts survival outcome
Jun. 5, 2023—The expected course of a patient's cancer prognosis has traditionally been judged by its type, stage and microscopic aggressiveness, but patients with the same presentation can still have widely divergent outcomes. Researchers from Vanderbilt-Ingram Cancer Center have discovered that differences in tumor mutation burden are a major reason for this divergence.
Liquid biopsy test may detect early-stage and low DNA-shedding cancers
May. 31, 2023—Vanderbilt research shows that a liquid biopsy-based multicancer early detection (MCED) test could detect 12 types of cancers, including low DNA-shedding cancers and early-stage cancers.
Study shows palliative care provided at point of oncology surgery does not improve patient outcomes
May. 11, 2023—New Vanderbilt research provides evidence that the addition of palliative care services earlier in the disease process, specifically to patients having surgery for cancer, does not demonstrate benefits to the patients.
Better adenoma detection
May. 4, 2023—Fluorescent nanoparticles clearly identified colonic adenomas — precursors to colorectal cancer — in mice, and the formulation should translate to clinical use in humans.